Alexander H. Moskovitz, MD, Nabil P

Slides:

Advertisements

Similar presentations

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E

Advertisements

The prognostic importance of the number of involved lymph nodes in esophageal cancer: Implications for revisions of the American Joint Committee on Cancer.

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

The Society of Thoracic Surgeons Lung Cancer Resection Risk Model: Higher Quality Data and Superior Outcomes Felix G. Fernandez, MD, MS, Andrzej S. Kosinski,

Mark W. Onaitis, MD, Rebecca P. Petersen, MD, John C

Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability? Tirone E. David, MD, Susan Armstrong, MS,

Usman Ahmad, MD, Haoxian Yang, MD, Camelia Sima, MD, MS, Daniel H

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Prognostic Factors Associated With Interventional Bronchoscopy in Lung Cancer Nicolas Guibert, MD, Julien Mazieres, MD, PhD, Benoît Lepage, MD, Gavin.

Meta-Analysis of Survival After Pleurectomy Decortication Versus Extrapleural Pneumonectomy in Mesothelioma Emanuela Taioli, MD, PhD, Andrea S. Wolf,

Lobectomy in Octogenarians With Non-Small Cell Lung Cancer: Ramifications of Increasing Life Expectancy and the Benefits of Minimally Invasive Surgery

Prognostic Variables in Thoracic Esophageal Squamous Cell Carcinoma

David T. Cooke, MD, Danh V. Nguyen, PhD, Ying Yang, MS, Steven L

Clinical T2-T3N0M0 Esophageal Cancer: The Risk of Node Positive Disease Brendon M. Stiles, MD, Farooq Mirza, MD, Anthony Coppolino, MD, Jeffrey L. Port,

Second Primary Lung Cancers: Smokers Versus Nonsmokers After Resection of Stage I Lung Adenocarcinoma R. Taylor Ripley, MD, Robert R. McMillan, MD, MPH,

Risk Factors for Lymph Node Metastases and Prognosticators of Survival in Patients Undergoing Pulmonary Metastasectomy for Colorectal Cancer Servet Bölükbas,

Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.

Brendon M. Stiles, MD, Farooq Mirza, MD, Jeffrey L. Port, MD, Paul C

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Linda Henry, PhD, RN, Linda Halpin, MSN, RN, Sharon Hunt, MBA, Sari D

Randomized controlled trial of a special acupuncture technique for pain after thoracotomy Gary Deng, MD, PhD, Valerie Rusch, MD, Andrew Vickers, PhD,

Andrea S. Wolf, MD, MPH, Scott J

Chris Dickhoff, MD, Max Dahele, MD, PhD, Sayed M

The prognostic importance of the number of involved lymph nodes in esophageal cancer: Implications for revisions of the American Joint Committee on Cancer.

Readmission to Intensive Care Unit After Initial Recovery From Major Thoracic Oncology Surgery Suk-Won Song, MD, Hyun-Sung Lee, MD, PhD, Jae-Hyun Kim,

Surgical Resection of Rare Esophageal Cancers

Conditional Cancer-Specific Versus Cardiovascular-Specific Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer Shawn S. Groth, MD, MS, Natasha.

Analyzing Effectiveness of Routine Pleural Drainage After Nuss Procedure: A Randomized Study Krystian Pawlak, MD, PhD, Łukasz Gąsiorowski, MD, PhD, Piotr.

The Relationship Between Hospital Surgical Case Volumes and Mortality Rates in Pediatric Cardiac Surgery: A National Sample, 1988–2005 Karl F. Welke,

Survival After Lobectomy Versus Segmentectomy for Stage I Non-Small Cell Lung Cancer: A Population-Based Analysis Bryan A. Whitson, MD, PhD, Shawn S.

Use of Amiodarone After Major Lung Resection

Is Repeat Pulmonary Metastasectomy Indicated for Soft Tissue Sarcoma?

Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer Raymond U.

Smoking Status as a Prognostic Factor in Patients with Stage I Pulmonary Adenocarcinoma Ichiro Yoshino, MD, PhD, Daigo Kawano, MD, Taro Oba, MD, Koji.

Feiran Lou, MD, MS, Camelia S. Sima, MD, MS, Prasad S

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Should Patients 60 Years and Older Undergo Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices? Jeremiah G. Allen, MD, Arman.

Robert R. McMillan, MD, MPH, Camelia S. Sima, MD, MS, Nicole H

Andrew P. Dhanasopon, MD, Michelle C. Salazar, MD, Jessica R

Brendon M. Stiles, MD, Mohamed K. Kamel, MD, Sebron W

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Matthew J. Bott, MD, Hanghang Wang, BA, William Travis, MD, Gregory J

Predictors of Long-Term Survival After Resection of Esophageal Carcinoma With Nonregional Nodal Metastases Paul C. Lee, MD, Jeffrey L. Port, MD, Subroto.

Surgical Therapy for Bilateral Multiple Primary Lung Cancer

Valerie W Rusch, MD, Ennapadam S Venkatraman, PhD

Predictors of Nodal Metastases for Clinical T2N0 Esophageal Adenocarcinoma Arianna Barbetta, MD, Francisco Schlottmann, MD, Tamar Nobel, MD, David B.

Eric S. Weiss, MD, MPH, Jeremiah G. Allen, MD, Christian A

Clinicopathologic Features of Submucosal Esophageal Squamous Cell Carcinoma Manabu Emi, MD, PhD, Jun Hihara, MD, PhD, Yoichi Hamai, MD, PhD, Takaoki Furukawa,

Phillip G. Rowse, MD, Dawn E

Nabil P. Rizk, MD, Venkatraman E. Seshan, PhD, Manjit S

Bernard J. Park, MD, Matthew Bacchetta, MD, Manjit S

Limitations of Hospital Volume as a Measure of Quality of Care for Coronary Artery Bypass Graft Surgery Karl F. Welke, MD, Mitchell J. Barnett, PharmD,

Early and Late Results of the Nuss Procedure in Surgical Treatment of Pectus Excavatum in Different Age Groups Krystian Pawlak, MD, PhD, Łukasz Gąsiorowski,

Risk Factors for Local Recurrence and Optimal Length of Esophagectomy in Esophageal Squamous Cell Carcinoma Chang Hyun Kang, MD, PhD, Yoohwa Hwang, MD,

Nael Martini: A Leader in Thoracic Surgical Oncology

Specialty Training and Mortality After Esophageal Cancer Resection

Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer Pamela Samson, MD, MPHS, Varun.

Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer? Anna Lee, MD, MPH, Andrew T.

Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,

Neoadjuvant and Adjuvant Chemotherapy in Resected Pulmonary Large Cell Neuroendocrine Carcinomas: A Single Institution Experience Inderpal S. Sarkaria,

Mark W. Hennon, MD, Elisabeth U

Raja M. Flores, MD, Bernard J

Survival Benefits of Postoperative Chemoradiation for Lymph Node–Positive Esophageal Squamous Cell Carcinoma Po-Kuei Hsu, MD, Chien-Sheng Huang, MD,

Mark I. Block, MD The Annals of Thoracic Surgery

Slide Tracheoplasty in Infants and Children: Risk Factors for Prolonged Postoperative Ventilatory Support Peter B. Manning, MD, Michael J. Rutter, MD,

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Benjamin D. Kozower, MD, MPH, Shubin Sheng, PhD, Sean M

Michael J. Weyant, MD, Manjit S

Thirty-Day Mortality Underestimates the Risk of Early Death After Major Resections for Thoracic Malignancies Robert R. McMillan, MD, MPH, Alexandra Berger,

Presentation transcript:

Mortality Increases for Octogenarians Undergoing Esophagogastrectomy for Esophageal Cancer Alexander H. Moskovitz, MD, Nabil P. Rizk, MD, Ennapadam Venkatraman, PhD, Manjit S. Bains, MD, Raja M. Flores, MD, Bernard J.H. Park, MD, Valerie W. Rusch, MD The Annals of Thoracic Surgery Volume 82, Issue 6, Pages 2031-2036 (December 2006) DOI: 10.1016/j.athoracsur.2006.06.053 Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Local linear logistic regression analysis of mortality rate by age as a continuous variable for all in-hospital deaths and any death within 2 months of operation. All deaths within 2 months of operation for patients age 75 and older occurred in the hospital. Mortality increases as a continuum, with the highest rate in patients older than 80 years of age. In this analysis, the estimated mortality rate for an 80-year-old is 12% (95% confidence interval, 6.7 to 21.2). The Annals of Thoracic Surgery 2006 82, 2031-2036DOI: (10.1016/j.athoracsur.2006.06.053) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Overall survival (calculated from the date of operation) for patients who had either esophageal adenocarcinoma or squamous cell carcinoma. Patients aged 80 years or older had a significantly worse survival. The number of patients at risk in each age group is shown at the bottom margin. The Annals of Thoracic Surgery 2006 82, 2031-2036DOI: (10.1016/j.athoracsur.2006.06.053) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions